Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]

Benzer Materyaller

• Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
  Yazar:: Buhl R, ve diğerleri
  Baskı/Yayın Bilgisi: (2012-10-01)
• Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
  Yazar:: Buhl, Roland, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]
  Baskı/Yayın Bilgisi: (2015)
• Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD
  Yazar:: D’Urzo, Anthony
  Baskı/Yayın Bilgisi: (2013)
• Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
  Yazar:: D'Urzo, Anthony, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)